Aligos Therapeutics SG&A Expense (Quarterly) Insights

Aligos Therapeutics Inc (ALGS)

0.77 -0.05 (-5.87%) USD | NASDAQ | Apr 26, 10:22

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2019. Upgrade now.

Date	Value
December 31, 2023	6.421M
September 30, 2023	6.443M
June 30, 2023	9.246M
March 31, 2023	8.506M
December 31, 2022	7.119M
September 30, 2022	5.263M
June 30, 2022	7.576M
March 31, 2022	6.452M
December 31, 2021	9.717M

Date	Value
September 30, 2021	6.473M
June 30, 2021	6.556M
March 31, 2021	5.781M
December 31, 2020	6.205M
September 30, 2020	4.225M
June 30, 2020	4.095M
March 31, 2020	3.419M
December 31, 2019	3.463M
September 30, 2019	2.775M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

2.775M

Minimum

Sep 2019

9.717M

Maximum

Dec 2021

6.096M

Average

6.432M

Median

SG&A Expense (Quarterly) Benchmarks